| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &Immunovant CEO | President &COO | Chief Operating Officer
1 company
Venker Eric is a President &Immunovant CEO at Roivant Sciences Ltd.. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $47.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2024 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 100,000 | $11.49 | $1,149,000.00 | -14.4% | -5.2% | +93.7% | |
| Nov 20, 2024 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 100,000 | $11.32 | $1,132,000.00 | -14.2% | -7.0% | +76.4% | |
| Oct 21, 2024 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 100,000 | $11.65 | $1,165,000.00 | -13.9% | -3.0% | +53.8% | |
| Feb 9, 2024 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 96,950 | $10.92 | $1,058,694.00 | -15.4% | +4.1% | +0.7% | |
| Oct 5, 2023 | ROIV Roivant Sciences Ltd. | Chief Operating Officer | Sale+OE | 1,200,000 | $10.43 | $12,520,989.82 | -40.2% | +4.1% | +9.1% | |
| Sep 27, 2023 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 500,000 | $13.02 | $6,510,000.00 | -45.6% | -13.0% | -12.3% | |
| Sep 8, 2023 | ROIV Roivant Sciences Ltd. | Chief Operating Officer | Sale+OE | 106,430 | $12.19 | $1,297,381.70 | -14.8% | -22.6% | -2.4% | |
| Sep 6, 2023 | ROIV Roivant Sciences Ltd. | Chief Operating Officer | Sale+OE | 93,964 | $11.91 | $1,119,340.80 | -4.9% | -16.7% | +3.4% | |
| Aug 14, 2023 | ROIV Roivant Sciences Ltd. | Chief Operating Officer | Sale+OE | 59,811 | $11.89 | $711,152.79 | -8.7% | -22.7% | -3.0% | |
| Aug 3, 2023 | ROIV Roivant Sciences Ltd. | Chief Operating Officer | Sale+OE | 44,629 | $11.93 | $532,423.97 | -6.6% | -21.2% | -8.6% |